HDFC Pharma and Healthcare Fund
Holdings
39
Concentrated
Top 10 weight
52%
Concentration
Strategy
Active
Portfolio style
Equity
100%
Asset allocation
Portfolio
3Sectors2Large positions71.2%Top: Pharmaceuticals & Biotechnology0.0%Cash
Market-cap allocation
Large cap34%
Mid cap28%
Small cap35%
Asset allocation
Equity100%
Top holdings
Sun Pharmaceutical Industries Ltd.EQUITY9.7%
Divis Laboratories Ltd.EQUITY9.1%
Max Healthcare Institute LimitedEQUITY4.8%
Aster DM Quality Care LimitedEQUITY4.7%
Lupin Ltd.EQUITY4.7%
Cipla Ltd.EQUITY4.6%
Alkem Laboratories Ltd.EQUITY3.7%
Acutaas Chemicals LimitedEQUITY3.6%
Anthem Biosciences LimitedEQUITY3.6%
Neuland Laboratories LimitedEQUITY3.4%
Sign in for free to unlock all 39 holdings →Portfolio insights
Portfolio read
- 100% equity.
- Large-cap exposure is 34%.
- Largest equity sector is Pharmaceuticals & Biotechnology at 71.2%.
Watchpoints
- Sector concentration is elevated: Pharmaceuticals & Biotechnology represents 71%.
Generated from current fund metrics. Educational research only.
Peer comparison
Other funds in Sectoral / Thematic.
Explore comparable funds →Sector exposure
Showing top sectors from the current portfolio.
Healthcare Services27.9%